The need for neuroscience nursing to change the current model ... Building on the Center to Advance Palliative Care model, the Parkinson's Disease Model of Care (PDMC) was developed to help ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

Lewy body diseases (LBDs) are a class of debilitating neurodegenerative disorders linked to the abnormal aggregation of the ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

I was recently opining — okay, whining — to one of my friends about my birthday, to which she responded, “Stop it, we’re aging like fine wine.” That ...

Goldman, MD, MPH, who, with colleagues, published the largest study to show high levels of TCE exposure are associated with an increased risk of Parkinson’s Disease. He explains some of the science ...